Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Daniel J. Dooley"'
Autor:
Phillip H. Lam, Daniel J. Dooley, Charles Faselis, Helen Sheriff, Gregg C. Fonarow, Charity J. Morgan, Ali Ahmed, Richard M. Allman, Cherinne Arundel, Wilbert S. Aronow
Publikováno v:
Archives of medical science : AMS, vol 17, iss 4
Archives of Medical Science : AMS
Archives of Medical Science : AMS
IntroductionHospital length of stay (LoS) and hospital readmissions are metrics of healthcare performance. We examined the association between these two metrics in older patients hospitalized with decompensated heart failure (HF).Material and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::066cf9bb69dc8310d933fca449b1daf3
https://doi.org/10.5114/aoms.2019.89702
https://doi.org/10.5114/aoms.2019.89702
Autor:
Gregg C. Fonarow, Richard M. Allman, Ali Ahmed, Phillip H. Lam, Daniel J. Dooley, Charity J. Morgan, Cherinne Arundel, Deepak L. Bhatt
Publikováno v:
The American Journal of Cardiology. 123:1840-1844
Heart failure (HF) is the leading cause for 30-day all-cause readmission in older Medicare beneficiaries and 30-day all-cause readmission is associated with a higher risk of mortality. In the current analysis, we examined if that association varied b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::714eed1a8a60195ff2a368f8f9952708
https://doi.org/10.1016/j.amjcard.2019.03.007
https://doi.org/10.1016/j.amjcard.2019.03.007
Autor:
Bertram Pitt, Prakash Deedwania, Gregg C. Fonarow, Ali Ahmed, Charity J. Morgan, Deepak L. Bhatt, Neha Gupta, Steven N. Singh, Michael R. Zile, Phillip H. Lam, Daniel J. Dooley
Publikováno v:
The American Journal of Medicine. 131:1473-1481
Background Beta-blockers in high target doses are recommended for heart failure with reduced ejection fraction (HFrEF) but not for preserved ejection fraction (HFpEF). Treatment benefits are often more pronounced in high-risk subgroups, and patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::489f739313448000dd4af87655c70a07
https://doi.org/10.1016/j.amjmed.2018.07.008
https://doi.org/10.1016/j.amjmed.2018.07.008
Autor:
Cherinne Arundel, Wilbert S. Aronow, Helen Sheriff, Ali Ahmed, Gregg C. Fonarow, Richard M. Allman, Finn Waagstein, Poonam Bhyan, Phillip H. Lam, Charity J. Morgan, Daniel J. Dooley, Selma F. Mohammed
Publikováno v:
Clinical Cardiology. 41:406-412
BACKGROUND: Digoxin use has been associated with a lower risk of 30‐day all‐cause admission and readmission in patients with heart failure and reduced ejection fraction (HFrEF). HYPOTHESIS: Digoxin use will be associated with improved outcomes in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e82ed3871cb5be74702493c6fc30c495
https://doi.org/10.1002/clc.22889
https://doi.org/10.1002/clc.22889
Autor:
Marc R. Blackman, Stefan D. Anker, Wilbert S. Aronow, Daniel E. Forman, Inmaculada Aban, Javed Butler, Ioannis Kanonidis, Phillip H. Lam, Deepak L. Bhatt, Prakash Deedwania, Chris Adamopoulos, Daniel J. Dooley, Gerasimos Filippatos, Bertram Pitt, Ross D. Fletcher, Gregg C. Fonarow, Kanan Patel, Michel White, Richard M. Allman, Cherinne Arundel, Ali Ahmed
Publikováno v:
European Journal of Heart Failure. 20:359-369
Aims To examine associations of below-target and target dose of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, with outcomes in patients with heart failure and reduced ejection fraction (HFrEF) in the Studies of Left Ventricular Dysfunc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::798a29eff07888ca46f572126a6e7715
https://doi.org/10.1002/ejhf.937
https://doi.org/10.1002/ejhf.937
Autor:
Phillip H, Lam, Daniel J, Dooley, Gregg C, Fonarow, Javed, Butler, Deepak L, Bhatt, Gerasimos S, Filippatos, Prakash, Deedwania, Daniel E, Forman, Michel, White, Ross D, Fletcher, Cherinne, Arundel, Marc R, Blackman, Chris, Adamopoulos, Ioannis E, Kanonidis, Inmaculada B, Aban, Kanan, Patel, Wilbert S, Aronow, Richard M, Allman, Stefan D, Anker, Bertram, Pitt, Ali, Ahmed
Publikováno v:
European journal of heart failure, vol 20, iss 2
AIMS: To examine associations of below-target and target dose of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, with outcomes in patients with heart failure and reduced ejection fraction (HFrEF) in the Studies of Left Ventricular Dysfun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cd9f93540d0eba470b2f6200f0312ef8
https://escholarship.org/uc/item/5sx8z9vw
https://escholarship.org/uc/item/5sx8z9vw
Publikováno v:
Circulation. 136
Background: According to 2017 update of 2013 ACCF/AHA HF guideline, systolic BP (SBP) should be lowered to Methods: Of the 10482 hospitalized pts with decompensated HFpEF (EF >40%) discharged alive, 2652 had HTN, defined as SBP ≥140 or DBP ≥90 mm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c5d1e4f4aa8dda4ee9bfd298012176d
https://doi.org/10.1161/circ.136.suppl_1.21189
https://doi.org/10.1161/circ.136.suppl_1.21189
Publikováno v:
Circulation. 136
Background: According to the 2017 update of the 2013 ACCF/AHA HF guideline, systolic BP (SBP) should be lowered to Methods: Of the 10482 hospitalized pts with decompensated HFpEF (EF >40%) discharged alive, 5514 had HTN, defined as SBP ≥140 or DBP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca4e7b431d919b37a4b41464e79827a3
https://doi.org/10.1161/circ.136.suppl_1.21191
https://doi.org/10.1161/circ.136.suppl_1.21191
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction
Autor:
Ali Ahmed, Richard M. Allman, Selma F. Mohammed, Stefan D. Anker, Cherinne Arundel, Steven N. Singh, Prakash Deedwania, Wen-Chih Wu, Marc R. Blackman, Phillip H. Lam, Thomas E. Love, Gurusher Panjrath, Daniel J. Dooley, Javed Butler, Charity J. Morgan, Michael R. Zile, Wilbert S. Aronow, Michel White, Gregg C. Fonarow, Deepak L. Bhatt
Publikováno v:
Journal of the American College of Cardiology. 70(15)
A lower heart rate is associated with better outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). Less is known about this association in patients with HF with preserved ejection fraction (HFpEF).The aims of this study we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eb0084a5f619122b3294e6071259316
https://pubmed.ncbi.nlm.nih.gov/28982500
https://pubmed.ncbi.nlm.nih.gov/28982500
Publikováno v:
Heart failure clinics. 13(3)
Positive inotropic drugs have long been studied for their potential benefits in patients with heart failure and reduced ejection fraction (HFrEF). Although there has been an extensive amount of research about the clinical effects of these drugs in ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e289111f4187fa9738665fd2ef8da3e0
https://pubmed.ncbi.nlm.nih.gov/28602370
https://pubmed.ncbi.nlm.nih.gov/28602370